Feature | Cardiovascular Business | June 07, 2024

In Memoriam: Stuart J. Connolly, MD

Stuart J. Connolly, MD

Stuart J. Connolly, MD


June 7, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the passing of arrhythmia medicine pioneer Stuart J. Connolly, MD, on June 2. 

According to his obituary published in the Hamilton Spectator, he completed a Bachelor of Philosophy at McGill University, then a Master of Philosophy at Fordham University, then returned to McGill where he graduated from medical school in 1977. Stuart met his wife Elaine during cardiology training at St Michael's Hospital in Toronto. After a year together they set off to Stanford University for post-doctoral training, then returned to join the faculty at McMaster University. In 1984 they moved to Lowville, where they would live for 36 years together until Elaine's passing in 2020. Stuart had a celebrated career as a cardiologist and researcher. His research impacted millions globally in the field of atrial fibrillation, stroke prevention and anticoagulation. He remained active in research until the very end of his life and is recognized worldwide as one of the most impactful clinical investigators in cardiac arrhythmia management, cited over 200,000 times to date. Among his over 400 publications, Stuart published 4 of his 26 New England Journal of Medicine papers in his final year. During his forty years at McMaster, Stuart founded the cardiac arrhythmia service and served as cardiology division director. Stuart mentored many promising clinicians and scientists at McMaster and at other institutions around the world, with great care and dedication, helping them to make meaningful and lasting impacts in their areas of investigation.

You can view the full tribute here.


Related Content

News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...

Home June 20, 2024
Home
Subscribe Now